INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53
申请人:Lacrampe Jean Fernand Armand
公开号:US20090149493A1
公开(公告)日:2009-06-11
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I) wherein n, m, p, s, t, R
1
, R
2
, A and Z have defined meanings.
US8232298B2
申请人:——
公开号:US8232298B2
公开(公告)日:2012-07-31
[EN] INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53<br/>[FR] INHIBITEURS DE L'INTERACTION ENTRE MDM2 ET P53
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2007107543A1
公开(公告)日:2007-09-27
[EN] The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I) wherein n, m, p, s, t, R1, R2, A and Z have defined meanings. [FR] La présente invention concerne des composés répondant à la formule (I), leur utilisation en tant qu'inhibiteur d'une interaction p53-MDM2 aussi bien que des compositions pharmaceutiques incluant lesdits composés de formule (I), n, m, p, s, t, R1, R2, A et Z ayant des significations déterminées.